Debaki R Howlader Selected Research

Bacillary Dysentery (Shigellosis)

10/2023	The L-DBF vaccine cross protects mice against different Shigella serotypes after prior exposure to the pathogen.
1/2023	Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.
12/2021	Development of a Self-Adjuvanting, Cross-Protective, Stable Intranasal Recombinant Vaccine for Shigellosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debaki R Howlader Research Topics

Disease

5	Infections 01/2024 - 01/2018
3	Bacillary Dysentery (Shigellosis) 10/2023 - 12/2021
1	Type I Syndactyly 12/2021
1	Pseudomonas Infections 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Typhoid Fever (Typhoid) 01/2018

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 01/2024 - 01/2018
2	Subunit VaccinesIBA 10/2023 - 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	CytokinesIBA 10/2023
1	AntibodiesIBA 10/2023
1	Protein Subunits (Protein Subunit)IBA 03/2023
1	dodecyldimethylamine oxideIBA 12/2021
1	Detergents (Detergent)IBA 12/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2021
1	Combined VaccinesIBA 01/2018